Clearmind Medicine Inc. (CMND)
NASDAQ: CMND
· Real-Time Price · USD
1.07
0.01 (0.94%)
At close: Sep 26, 2025, 11:00 AM
0.94% (1D)
| Bid | 0.76 |
| Market Cap | 5.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.83M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -1.43 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.36 |
| Volume | 68,450 |
| Avg. Volume (20D) | 1,440,711 |
| Open | 1.08 |
| Previous Close | 1.06 |
| Day's Range | 1.05 - 1.09 |
| 52-Week Range | 0.80 - 2.18 |
| Beta | -1.24 |
| Ex-Dividend Date | n/a |
About CMND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMND
Website n/a
1 week ago
+19%
Clearmind Medicine shares are trading higher after...
Unlock content with
Pro Subscription
2 months ago
+21.82%
Clearmind Medicine shares are trading higher after the company announced IRB approval for its Phase 1/2a clinical trial for alcohol use disorder at Tel Aviv Sourasky Medical Center.
